(Q42628342)

4 November 2017

title

The long-term efficacy and tolerability of donepezil in patients with vascular dementia (English)

1 reference

4 November 2017

David Wilkinson

1

1 reference

4 November 2017

Gustavo Róman

2

1 reference

4 November 2017

Stephen Salloway

3

1 reference

4 November 2017

Jane Hecker

4

1 reference

4 November 2017

Karyn Boundy

5

1 reference

4 November 2017

Dinesh Kumar

6

1 reference

4 November 2017

Holly Posner

7

1 reference

4 November 2017

Rachel Schindler

8

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

International Journal of Geriatric Psychiatry

4 November 2017

published in

1 reference

4 November 2017

volume

25

1 reference

4 November 2017

issue

3

1 reference

4 November 2017

page(s)

305-313

1 reference

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

4 November 2017

cites work

1 reference

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 years

21 January 2018

1 reference

Donepezil in vascular dementia: a randomized, placebo-controlled study

21 January 2018

1 reference

Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia

21 January 2018

1 reference

7 January 2021

Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial

1 reference

7 January 2021

Frontal impairment in subcortical ischemic vascular dementia in comparison to Alzheimer's disease.

1 reference

7 January 2021

Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease

1 reference

7 January 2021

The incidence of vascular dementia in Canada: a comparison with Europe and East Asia

1 reference

7 January 2021

Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials

1 reference

7 January 2021

Investigating the natural course and treatment of vascular dementia and Alzheimer's disease. Parallel study populations in two randomized, placebo-controlled trials.

1 reference

7 January 2021

Patient populations in clinical trials of the efficacy and tolerability of donepezil in patients with vascular dementia

1 reference

7 January 2021

Donepezil in vascular dementia: combined analysis of two large-scale clinical trials

1 reference

7 January 2021

Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia.

1 reference

7 January 2021

The relationship between quality of life, Mini-Mental State Examination, and the Instrumental Activities of Daily Living in patients with Alzheimer's disease

1 reference

7 January 2021

Identifiers

DOI

10.1002/GPS.2340

1 reference

4 November 2017

1 reference